1 Day
Source:
المشهد العربي
Trump sets two-year deadline for drug manufacturing shift
U.S. President Donald Trump issued a decree granting pharmaceutical companies a two-year deadline to relocate their manufacturing lines within the United States, accompanied by a threat to impose a 100% tariff by August 2028 on companies that fail to comply. The aim of this measure is to bring pharmaceutical supply chains back to America, especially for low-cost drugs such as antibiotics, cancer medications, and cholesterol treatments, which currently rely on imports from India, China, and Europe. Trump also confirmed that the tariffs will remain in effect on patented and trademarked drugs without any changes.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)